Byrna Technologies Inc. BYRN has seen a sharp fall in its stock price, declining 39% in three months compared to the broader ...

Today’s Forbes Daily covers the latest attack on higher ed, polls souring on Trump, how a Musk assistant became an investor, ...

Let's take a look at why it is worth tracking these three stocks for the next three months: Coromandel International Ltd: A ...

Relative to the broader stock market, Dividend Kings are a very tiny group. A company becomes a Dividend King after ...

Mark Zuckerberg considered spinning off Instagram into a separate company in 2018 as he increasingly became concerned that ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Berkshire Hathaway was a relatively early investor in BYD, betting $230 million on the Chinese electric vehicle (EV) start-up for just $1.02 per share. Now, that equity stake is worth $2.24 billion, ...

(AP Photo/Seth Wenig) Traders work on the floor at the New York Stock Exchange in New York, Tuesday, April 8, 2025. (AP Photo/Seth Wenig) Mike Pistillo Jr. works on the floor at the New York Stock ...

Multiple data readouts expected this year could be a catalyst for the stock. Image source: Getty Images. With cystic fibrosis therapies remaining the core business, Vertex has posted impressive ...

Investing.com -- Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) rose 9% following the announcement of positive results from its Phase 3 TRANSCEND trial, which met its primary endpoint with a ...